Ranka Vukotic

This study analyzes mutations in neural signaling pathways across cancers, finding 65% of patients have alterations linked to poor survival and complex pathway interactions.

The paper analyzes cell-cell interactions (CCIs) in transcriptomic data, showing they are more co-expressed in cancer and associated with patient survival and immunotherapy response.

The paper analyzes GPCR signaling dysregulation in cancer transcriptomics data to identify therapeutic targets and survival-associated signaling axes.